Pharmacologic treatment of irritable bowel syndrome. Position statement of the Asociación Mexicana de Gastroenterología, 2024 J.M. Remes-Troche; E. Coss-Adame; M. Schmulson; K.R. García-Zermeño; M. Amieva-Balmori; R. Carmona-Sánchez; O. Gómez-Escudero; P.C. Gómez-Castaños; M.E. Icaza-Chávez; A. López-Colombo; E.C. Morel-Cerda; M.Á. Valdovinos-Díaz; L.R. Valdovinos-García; A.S. Villar-Chávez;

Weight change and lifestyle modifications implemented during the COVID-19 pandemic lockdown are associated with the development of gastrointestinal symptoms F. Higuera-de-la-Tijera; A. Servín-Caamaño; F. Lajud-Barquín; A. Tovar-Aguilar;

Two consecutive attacks of diarrhea in 15 COVID-19 patients: An antibiotic-associated one following the viral one R. Maslennikov; V. Ivashkin; A. Ufimtseva; E. Poluektova;